Anti-BCMA CAR T-Cell Therapy in Multiple Myeloma. Reply
N Engl J Med
.
2019 Jul 18;381(3):e6.
doi: 10.1056/NEJMc1907520.
Authors
Noopur Raje
1
,
Kristen Hege
2
,
James N Kochenderfer
3
Affiliations
1
Massachusetts General Hospital Cancer Center, Boston, MA.
2
Celgene, San Francisco, CA.
3
National Cancer Institute, Bethesda, MD kochendj@mail.nih.gov.
PMID:
31314982
DOI:
10.1056/NEJMc1907520
No abstract available
Publication types
Letter
Comment
MeSH terms
Cell Line, Tumor
Humans
Immunotherapy, Adoptive*
Multiple Myeloma*
T-Lymphocytes